Femasys (FEMY)
(Real Time Quote from BATS)
$1.27 USD
+0.05 (4.10%)
Updated Oct 18, 2024 03:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
FEMY 1.27 +0.05(4.10%)
Will FEMY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for FEMY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FEMY
Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device
Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI
FEMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
Other News for FEMY
Femasys to exhibit at ASRM 2024, participate in KEEPR Education Program
Femasys announces second order from strategic distribution partners
Femasys Announces Infertility Clinic Customers from Coast to Coast
Femasys announes infertility clinic customers from coast to coast
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed? for over $1.3M in Spanish Market